OXFORD ASSET MANAGEMENT LLP - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 94 filers reported holding RECRO PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2019$972,000
-46.2%
53,004
-67.5%
0.03%
-37.2%
Q3 2019$1,806,000
+78.3%
163,028
+63.7%
0.04%
+95.5%
Q2 2019$1,013,000
-17.0%
99,577
-42.1%
0.02%
-31.2%
Q4 2018$1,221,000
+62.6%
171,936
+61.4%
0.03%
+100.0%
Q3 2018$751,000
-22.8%
106,552
-46.3%
0.02%
-15.8%
Q2 2018$973,000
-63.7%
198,549
-18.5%
0.02%
-66.7%
Q1 2018$2,682,000
+85.0%
243,598
+58.7%
0.06%
+83.9%
Q4 2017$1,450,000
+9.8%
153,489
+5.0%
0.03%
+24.0%
Q3 2017$1,321,000
-7.6%
146,130
-28.2%
0.02%
-10.7%
Q2 2017$1,430,000
+273.4%
203,430
+364.3%
0.03%
+211.1%
Q1 2017$383,00043,8110.01%
Other shareholders
RECRO PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders